FDA
-
-
-
-
-
-
-
AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 Gastrointestinal Infections
-
-
-
-
-
-
-
Moderna (MRNA) COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint, 94.5% Effective
-
-
-
-
-
-
-
PPD Expands Laboratory Test Portfolio for COVID-19 Therapy and Vaccine Development Programs
-
-
251,865 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All